{"transactions":[{"id":679977,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-08-20T20:31:29.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":3086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the RSU Award shall vest over 3 years, with 2/36 of the total shares underlying the RSU Award vesting on August 18, 2026; 3/36 of the total shares underlying the RSU Award vesting on November 18, 2026 and each November 18 thereafter; 4/36 of the total shares underlying the RSU Award vesting on March 10, 2027 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting on May 18, 2027 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award vesting on August 18, 2027 and each August 18 thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying the RSU Award shall vest over 3 years, with 2/36 of the total shares underlying the RSU Award vesting on August 18, 2026; 3/36 of the total shares underlying the RSU Award vesting on November 18, 2026 and each November 18 thereafter; 4/36 of the total shares underlying the RSU Award vesting on March 10, 2027 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting on May 18, 2027 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award vesting on August 18, 2027 and each August 18 thereafter."}],"balance_after":52469,"derivative":{"underlying":"Common Stock","underlying_shares":3086},"source":{"system":"sec-edgar","filing":"0001181190-26-000007","document":"form4-08202026_080825.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000118119026000007/form4-08202026_080825.xml","form_type":"4"}},{"id":679976,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T20:31:29.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":3086,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":3086,"source":{"system":"sec-edgar","filing":"0001181190-26-000007","document":"form4-08202026_080825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000118119026000007/form4-08202026_080825.xml","form_type":"4"}},{"id":740026,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-12T23:31:29.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":29835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/36 of the total shares subject to the option shall vest monthly over 3 years following the grant date of June 10, 2026."}],"balance_after":29835,"derivative":{"exercise_price":4.05,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":29835},"source":{"system":"sec-edgar","filing":"0001181190-26-000005","document":"form4-06122026_110625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000118119026000005/form4-06122026_110625.xml","form_type":"4"}},{"id":740025,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-12T23:31:29.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":55555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2026; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2026 and each November 18 thereafter; 4/36 of the total shares underlying the RSU Award shall vest on March 10, 2027 and each March 10 thereafter; 3/36  of the total shares underlying the RSU Award vesting shall vest on May 18, 2027 and each May 18 thereafter; and 3/36  of the total shares underlying the RSU Award shall vest on August 18, 2027 and each August 18 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"2/36 of the total shares subject to the RSU Award shall vest on August 18, 2026; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2026 and each November 18 thereafter; 4/36 of the total shares underlying the RSU Award shall vest on March 10, 2027 and each March 10 thereafter; 3/36  of the total shares underlying the RSU Award vesting shall vest on May 18, 2027 and each May 18 thereafter; and 3/36  of the total shares underlying the RSU Award shall vest on August 18, 2027 and each August 18 thereafter, until fully vested."}],"balance_after":55555,"derivative":{"underlying":"Common Stock","underlying_shares":55555},"source":{"system":"sec-edgar","filing":"0001181190-26-000005","document":"form4-06122026_110625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000118119026000005/form4-06122026_110625.xml","form_type":"4"}},{"id":758792,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T21:05:26.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 28, 2027 or (b) the Reporting Person's Board-approved separation of service from the Issuer or change in control of the Issuer, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":401816,"source":{"system":"sec-edgar","filing":"0001181190-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000118119026000002/ownership.xml","form_type":"4"}},{"id":776218,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:05:04.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":2239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":2239,"derivative":{"exercise_price":103.38,"exercise_date":"2027-05-14","expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":2239},"source":{"system":"sec-edgar","filing":"0001193125-26-228891","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228891/ownership.xml","form_type":"4"}},{"id":776217,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:05:04.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Muir was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The Reporting Person has elected to defer settlement of these restricted stock units pursuant to the Repligen Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the separation of the Reporting Person's service as a Director. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":40051,"source":{"system":"sec-edgar","filing":"0001193125-26-228891","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526228891/ownership.xml","form_type":"4"}},{"id":787891,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-08T18:48:02.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":2434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable."}],"balance_after":2434,"derivative":{"exercise_price":38.76,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":2434},"source":{"system":"sec-edgar","filing":"0001193125-26-214293","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526214293/ownership.xml","form_type":"4"}},{"id":787890,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-08T18:48:02.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":2434,"price":38.76,"value":94341.84,"ownership":{"direct":true},"balance_after":39056,"source":{"system":"sec-edgar","filing":"0001193125-26-214293","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526214293/ownership.xml","form_type":"4"}},{"id":966631,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-17T21:30:06.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":3366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable."}],"balance_after":3366,"derivative":{"exercise_price":26.12,"expiration_date":"2026-05-11","underlying":"Common Stock","underlying_shares":3366},"source":{"system":"sec-edgar","filing":"0001193125-25-322821","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525322821/ownership.xml","form_type":"4"}},{"id":966630,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:30:06.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":3366,"price":26.12,"value":87919.92,"ownership":{"direct":true},"balance_after":36622,"source":{"system":"sec-edgar","filing":"0001193125-25-322821","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525322821/ownership.xml","form_type":"4"}},{"id":1014752,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-22T20:45:04.000Z","date":"2025-10-20","kind":"grant","planned":false,"acquired":true,"shares":7554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a restricted stock unit (\"RSU\") award that vested immediately upon the grant."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a right to receive one share of the Issuer's common stock."}],"balance_after":371816,"source":{"system":"sec-edgar","filing":"0001193125-25-246921","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000119312525246921/ownership.xml","form_type":"4"}},{"id":1133529,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-27T21:00:08.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 22, 2026 or (b) the Reporting Person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":364262,"source":{"system":"sec-edgar","filing":"0000950170-25-077824","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017025077824/ownership.xml","form_type":"4"}},{"id":1144324,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T00:19:08.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 15, 2026, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":1800,"derivative":{"exercise_price":123.26,"exercise_date":"2026-05-15","expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":1800},"source":{"system":"sec-edgar","filing":"0000950170-25-074752","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017025074752/ownership.xml","form_type":"4"}},{"id":1144323,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-20T00:19:08.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Muir was awarded 973 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 15, 2026, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":33256,"source":{"system":"sec-edgar","filing":"0000950170-25-074752","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017025074752/ownership.xml","form_type":"4"}},{"id":1276676,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-10T22:18:21.000Z","date":"2025-02-07","kind":"other","planned":false,"acquired":true,"shares":44444,"price":2.25,"value":99999.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 7, 2025, the Reporting Person purchased 44,444 shares of the Issuer's Common Stock in connection with a firm commitment underwritten offering."}],"balance_after":334262,"source":{"system":"sec-edgar","filing":"0000950170-25-017195","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017025017195/ownership.xml","form_type":"4"}},{"id":1357988,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-20T19:29:56.000Z","date":"2024-11-19","kind":"exercise","planned":false,"acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":36.29,"expiration_date":"2025-09-14","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0000950170-24-129145","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024129145/ownership.xml","form_type":"4"}},{"id":1357987,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-20T19:29:56.000Z","date":"2024-11-19","kind":"exercise","planned":false,"acquired":true,"shares":19000,"price":36.29,"value":689510.0,"ownership":{"direct":true},"balance_after":32283,"source":{"system":"sec-edgar","filing":"0000950170-24-129145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024129145/ownership.xml","form_type":"4"}},{"id":1403675,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T20:15:04.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":0.3,"expiration_date":"2025-09-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-107788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024107788/ownership.xml","form_type":"4"}},{"id":1403674,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T20:15:04.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":5.3,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-107788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024107788/ownership.xml","form_type":"4"}},{"id":1403673,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T20:15:04.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":2.83,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-107788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024107788/ownership.xml","form_type":"4"}},{"id":1403672,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T20:15:04.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each \"Stock Option\") that was outstanding immediately prior to the Effective Time became fully vested and was cancelled at the Effective Time and converted into the right to receive an amount in cash equal to the product of (x) the total number of shares of common stock subject to such Stock Option immediately prior to the Effective Time multiplied by (y) the excess, if any, of the Merger Consideration over the applicable exercise price per share under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":2.99,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-107788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024107788/ownership.xml","form_type":"4"}},{"id":1403671,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T20:15:04.000Z","date":"2024-09-18","kind":"other","planned":false,"acquired":false,"shares":185358,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each share of common stock held by the Reporting Person was tendered in exchange for the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each share of common stock held by the Reporting Person was tendered in exchange for the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-107788","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024107788/ownership.xml","form_type":"4"}},{"id":1403670,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T20:15:04.000Z","date":"2024-09-18","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 6, 2024, among the Issuer, Pharmacosmos A/S, a Danish Aktieselskab (\"Parent\"), and Genesis Merger Sub, Inc. (\"Purchaser\"), an indirect wholly-owned subsidiary of Parent, Purchaser completed a tender offer for shares of common stock of the Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of September 18, 2024, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive $7.15 per share in cash, without interest and subject to any applicable withholding taxes (the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Merger Agreement, at the Effective Time, each outstanding deferred stock unit (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive an amount in cash equal to the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of August 6, 2024, among the Issuer, Pharmacosmos A/S, a Danish Aktieselskab (\"Parent\"), and Genesis Merger Sub, Inc. (\"Purchaser\"), an indirect wholly-owned subsidiary of Parent, Purchaser completed a tender offer for shares of common stock of the Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of September 18, 2024, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive $7.15 per share in cash, without interest and subject to any applicable withholding taxes (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Merger Agreement, at the Effective Time, each outstanding deferred stock unit (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive an amount in cash equal to the Merger Consideration."}],"balance_after":185358,"source":{"system":"sec-edgar","filing":"0000950170-24-107788","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024107788/ownership.xml","form_type":"4"}},{"id":1412782,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-06T21:05:03.000Z","date":"2024-09-05","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.8,"value":20000.0,"ownership":{"direct":true},"balance_after":289818,"source":{"system":"sec-edgar","filing":"0000950170-24-104427","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024104427/ownership.xml","form_type":"4"}},{"id":1419037,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T21:15:02.000Z","date":"2024-08-29","kind":"purchase","planned":false,"acquired":true,"shares":12224,"price":0.85,"value":10390.4,"ownership":{"direct":true},"balance_after":264818,"source":{"system":"sec-edgar","filing":"0000950170-24-102437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024102437/ownership.xml","form_type":"4"}},{"id":1419036,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T21:15:02.000Z","date":"2024-08-28","kind":"purchase","planned":false,"acquired":true,"shares":12776,"price":0.85,"value":10859.6,"ownership":{"direct":true},"balance_after":252594,"source":{"system":"sec-edgar","filing":"0000950170-24-102437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024102437/ownership.xml","form_type":"4"}},{"id":1426599,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-21T21:15:02.000Z","date":"2024-08-20","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1,"value":25000.0,"ownership":{"direct":true},"balance_after":239818,"source":{"system":"sec-edgar","filing":"0000950170-24-099560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024099560/ownership.xml","form_type":"4"}},{"id":1431421,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-16T21:15:04.000Z","date":"2024-08-14","kind":"purchase","planned":false,"acquired":true,"shares":25171,"price":0.75,"value":18878.25,"ownership":{"direct":true},"balance_after":214818,"source":{"system":"sec-edgar","filing":"0000950170-24-098142","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024098142/ownership.xml","form_type":"4"}},{"id":1444907,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-01T21:04:27.000Z","date":"2024-08-01","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":36.29,"expiration_date":"2025-09-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-24-089409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024089409/ownership.xml","form_type":"4"}},{"id":1444906,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T21:04:27.000Z","date":"2024-08-01","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":36.29,"value":181450.0,"ownership":{"direct":true},"balance_after":13283,"source":{"system":"sec-edgar","filing":"0000950170-24-089409","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024089409/ownership.xml","form_type":"4"}},{"id":1479143,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-14T20:41:33.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option will vest in their entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":2.99,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-24-005082","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000156218024005082/primarydocument.xml","form_type":"4"}},{"id":1479142,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T20:41:33.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in its entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director. The Reporting Person has elected to defer vesting of these shares pursuant to the G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors.  The RSUs will vest upon termination of the Reporting Person's service as a Director on the Company's Board."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents (i) 185,358 shares of common stock; (ii) 10,000 RSUs from award granted on June 15, 2023; and (iii) 10,000 RSUs from award granted on June 13, 2024."}],"balance_after":205358,"source":{"system":"sec-edgar","filing":"0001562180-24-005082","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000156218024005082/primarydocument.xml","form_type":"4"}},{"id":1490151,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T00:14:46.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 30, 2025, or (b) the reporting person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the reporting person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":189647,"source":{"system":"sec-edgar","filing":"0000950170-24-069564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000095017024069564/ownership.xml","form_type":"4"}},{"id":1510023,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-20T22:49:13.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":1376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 16, 2025, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":1376,"derivative":{"exercise_price":171.03,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":1376},"source":{"system":"sec-edgar","filing":"0000950170-24-062597","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024062597/ownership.xml","form_type":"4"}},{"id":1510022,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-20T22:49:13.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Muir was awarded 701 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 16, 2025, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":8283,"source":{"system":"sec-edgar","filing":"0000950170-24-062597","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024062597/ownership.xml","form_type":"4"}},{"id":1852460,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-16T20:07:07.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option will vest in their entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":2.83,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-23-005270","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000156218023005270/primarydocument.xml","form_type":"4"}},{"id":1852459,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:07:07.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in its entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director. The Reporting Person has elected to defer vesting of these shares pursuant to the G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors.  The RSUs will vest upon termination of the Reporting Person's service as a Director on the Company's Board."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents (i) 175,358 shares of common stock; (ii) 10,000 RSUs from award granted on June 23, 2022; and (iii) 10,000 RSUs from award granted on June 15, 2023."}],"balance_after":195358,"source":{"system":"sec-edgar","filing":"0001562180-23-005270","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000156218023005270/primarydocument.xml","form_type":"4"}},{"id":1874978,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-31T01:05:12.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":36364,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 23, 2024, or (b) the reporting person's Board-approved separation of service from the Issuer, in each case subject to continuous service of the reporting person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects an adjustment to total holdings to include 12 RSUs inadvertently excluded in prior reports."}],"balance_after":164647,"source":{"system":"sec-edgar","filing":"0001062993-23-012485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000106299323012485/form4.xml","form_type":"4"}},{"id":1883662,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-23T01:21:44.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":1487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 18, 2024, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":1487,"derivative":{"exercise_price":156.63,"exercise_date":"2024-05-18","expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":1487},"source":{"system":"sec-edgar","filing":"0000899243-23-013667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924323013667/doc4.xml","form_type":"4"}},{"id":1883661,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T01:21:44.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Muir was awarded 686 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 18, 2024, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":7582,"source":{"system":"sec-edgar","filing":"0000899243-23-013667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924323013667/doc4.xml","form_type":"4"}},{"id":2222141,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-24T20:51:10.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option will vest in their entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":5.3,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-22-005350","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000156218022005350/primarydocument.xml","form_type":"4"}},{"id":2222140,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T20:51:10.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in its entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 175,358 shares of common stock and 10,000 restricted stock units"}],"balance_after":185358,"source":{"system":"sec-edgar","filing":"0001562180-22-005350","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000156218022005350/primarydocument.xml","form_type":"4"}},{"id":2252349,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-01T00:17:28.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":1298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":1298,"derivative":{"exercise_price":159.17,"exercise_date":"2023-05-26","expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":1298},"source":{"system":"sec-edgar","filing":"0000899243-22-020276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924322020276/doc4.xml","form_type":"4"}},{"id":2252348,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T00:17:28.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Muir was awarded 534 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":6896,"source":{"system":"sec-edgar","filing":"0000899243-22-020276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924322020276/doc4.xml","form_type":"4"}},{"id":2251551,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T20:28:55.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":38910,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 26, 2023, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects an adjustment to total holdings to exclude 12 RSUs inadvertently included in prior reports."}],"balance_after":128271,"source":{"system":"sec-edgar","filing":"0001062993-22-013869","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000106299322013869/form4.xml","form_type":"4"}},{"id":2661355,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-21T20:05:54.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":19620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option will vest in their entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director."}],"balance_after":19620,"derivative":{"exercise_price":21.97,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":19620},"source":{"system":"sec-edgar","filing":"0001562180-21-004394","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000156218021004394/primarydocument.xml","form_type":"4"}},{"id":2661354,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T20:05:54.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":4389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in its entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer common stock"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents 170,969 shares of common stock and 4,389 restricted stock units"}],"balance_after":175358,"source":{"system":"sec-edgar","filing":"0001562180-21-004394","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000156218021004394/primarydocument.xml","form_type":"4"}},{"id":2689131,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-01T22:28:00.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":7137,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 27, 2022, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":89373,"source":{"system":"sec-edgar","filing":"0001062993-21-005245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000106299321005245/form4.xml","form_type":"4"}},{"id":2711554,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-18T01:57:42.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":1151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full on the earlier of May 13, 2022, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined."}],"balance_after":1151,"derivative":{"exercise_price":169.65,"exercise_date":"2022-05-13","expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":1151},"source":{"system":"sec-edgar","filing":"0000899243-21-019712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924321019712/doc4.xml","form_type":"4"}},{"id":2711553,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-18T01:57:42.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Muir was awarded 457 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 13, 2022, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":6362,"source":{"system":"sec-edgar","filing":"0000899243-21-019712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924321019712/doc4.xml","form_type":"4"}},{"id":2973385,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T21:54:08.000Z","date":"2020-11-18","kind":"purchase","acquired":true,"shares":50000,"price":13.5,"value":675000.0,"ownership":{"direct":true},"balance_after":170969,"source":{"system":"sec-edgar","filing":"0001562180-20-006801","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000156218020006801/primarydocument.xml","form_type":"4"}},{"id":3064924,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-07T21:07:45.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":18513,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) August 5, 2021, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":82236,"source":{"system":"sec-edgar","filing":"0001192482-20-000647","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000119248220000647/edgar.xml","form_type":"4"}},{"id":3112097,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-12T20:39:34.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest in their entirety twelve months after June 11, 2020, subject to the Reporting Person's continued service as a director."}],"balance_after":20000,"derivative":{"exercise_price":17.59,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-036301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000120919120036301/doc4.xml","form_type":"4"}},{"id":3132407,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-28T20:51:12.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 26, 2021, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":63723,"source":{"system":"sec-edgar","filing":"0001192482-20-000412","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000119248220000412/edgar.xml","form_type":"4"}},{"id":3144640,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-20T00:42:38.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":1285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full one year from grant date on May 13, 2021."}],"balance_after":1285,"derivative":{"exercise_price":128.18,"exercise_date":"2021-05-13","expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":1285},"source":{"system":"sec-edgar","filing":"0000899243-20-013632","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924320013632/doc4.xml","form_type":"4"}},{"id":3144639,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T00:42:38.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Muir was awarded 527 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 13, 2021. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":5905,"source":{"system":"sec-edgar","filing":"0000899243-20-013632","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924320013632/doc4.xml","form_type":"4"}},{"id":3489775,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T20:32:39.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest in their entirety twelve months after June 12, 2019, subject to the Reporting Person's continued service as a director."}],"balance_after":20000,"derivative":{"exercise_price":18.47,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-037146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000120919119037146/doc4.xml","form_type":"4"}},{"id":3507678,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-30T20:50:38.000Z","date":"2019-05-28","kind":"grant","acquired":true,"shares":7347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall vest on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."}],"balance_after":7347,"derivative":{"exercise_price":13.43,"expiration_date":"2029-05-27","underlying":"Common Stock","underlying_shares":7347},"source":{"system":"sec-edgar","filing":"0001209191-19-033453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000120919119033453/doc4.xml","form_type":"4"}},{"id":3507677,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-30T20:50:38.000Z","date":"2019-05-28","kind":"grant","acquired":true,"shares":3723,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the earlier of (a) May 28, 2029, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":43723,"source":{"system":"sec-edgar","filing":"0001209191-19-033453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000120919119033453/doc4.xml","form_type":"4"}},{"id":3522796,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-17T20:10:32.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":2109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full one year from grant date on May 15, 2020."}],"balance_after":2109,"derivative":{"exercise_price":67.71,"exercise_date":"2020-05-15","expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":2109},"source":{"system":"sec-edgar","filing":"0000899243-19-013990","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924319013990/doc4.xml","form_type":"4"}},{"id":3522795,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-17T20:10:32.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Muir was awarded 923 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":5378,"source":{"system":"sec-edgar","filing":"0000899243-19-013990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924319013990/doc4.xml","form_type":"4"}},{"id":3872805,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-05T20:38:10.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":8767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The performance criterion for vesting of this option was met upon the closing of the Issuer's initial public offering.  One twelfth (1/12th) of the shares subject to the option vested or shall vest monthly commencing on March 16, 2018, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":8767,"derivative":{"exercise_price":5.22,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":8767},"source":{"system":"sec-edgar","filing":"0001209191-18-041659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000120919118041659/doc4.xml","form_type":"4"}},{"id":3872804,"issuer":{"id":6248,"kind":"organization","name":"Neuronetics, Inc."},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T20:38:10.000Z","date":"2018-07-02","kind":"purchase","acquired":true,"shares":40000,"price":17,"value":680000.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-18-041659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000120919118041659/doc4.xml","form_type":"4"}},{"id":3898572,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-11T16:13:26.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest in their entirety twelve months after June 7, 2018, subject to the Reporting Person's continued service as a director."}],"balance_after":10000,"derivative":{"exercise_price":38.39,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-036867","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000120919118036867/doc4.xml","form_type":"4"}},{"id":3929909,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-17T20:44:31.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":3304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full one year from grant date on May 16, 2019."}],"balance_after":3304,"derivative":{"exercise_price":42.07,"exercise_date":"2019-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":3304},"source":{"system":"sec-edgar","filing":"0001140361-18-024450","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000114036118024450/doc1.xml","form_type":"4"}},{"id":3929908,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T20:44:31.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":1486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Muir was awarded 1,486 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 16, 2019. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":4455,"source":{"system":"sec-edgar","filing":"0001140361-18-024450","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000114036118024450/doc1.xml","form_type":"4"}},{"id":4257798,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-13T23:41:52.000Z","date":"2017-07-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in thirty-six monthly installments at the end of each successive month following July 11, 2017, subject to the Reporting Person's continued service as a director."}],"balance_after":20000,"derivative":{"exercise_price":15.55,"expiration_date":"2027-07-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-045118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000120919117045118/doc4.xml","form_type":"4"}},{"id":4270262,"issuer":{"id":7620,"kind":"organization","name":"Lifeward Ltd.","symbol":"LFWD"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to buy)","published_at":"2017-06-29T13:11:14.000Z","date":"2017-06-27","kind":"grant","acquired":true,"shares":4176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant."}],"balance_after":4176,"derivative":{"exercise_price":2.1,"expiration_date":"2027-06-27","underlying":"Ordinary Shares, par value NIS 0.01 per share","underlying_shares":4176},"source":{"system":"sec-edgar","filing":"0001628280-17-006805","document":"wf-form4_149874186104195.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000162828017006805/wf-form4_149874186104195.xml","form_type":"4"}},{"id":4306636,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2017-05-24T23:58:16.000Z","date":"2017-05-22","kind":"exercise","acquired":false,"shares":302908,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Preferred Stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering pursuant to the Issuer's Fifth Amended and Restated Certificate of Incorporation, as amended, based on the conversion rate in effect at the time of conversion. The Series C Preferred Stock converted to Common Stock on a 1-for-3 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Preferred Stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering pursuant to the Issuer's Fifth Amended and Restated Certificate of Incorporation, as amended, based on the conversion rate in effect at the time of conversion. The Series C Preferred Stock converted to Common Stock on a 1-for-3 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series C Preferred Stock automatically converted into shares of Common Stock upon consummation of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series C Preferred Stock automatically converted into shares of Common Stock upon consummation of the Issuer's initial public offering and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":100969},"source":{"system":"sec-edgar","filing":"0001209191-17-035152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000120919117035152/doc4.xml","form_type":"4"}},{"id":4306635,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-24T23:58:16.000Z","date":"2017-05-22","kind":"purchase","acquired":true,"shares":20000,"price":15,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects shares the reporting person purchased in the initial public offering at the initial public offering price of $15.00 per share."}],"balance_after":120969,"source":{"system":"sec-edgar","filing":"0001209191-17-035152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000120919117035152/doc4.xml","form_type":"4"}},{"id":4306634,"issuer":{"id":87413,"kind":"organization","name":"G1 Therapeutics, Inc.","symbol":"GTHX"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-24T23:58:16.000Z","date":"2017-05-22","kind":"exercise","acquired":true,"shares":100969,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Preferred Stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering pursuant to the Issuer's Fifth Amended and Restated Certificate of Incorporation, as amended, based on the conversion rate in effect at the time of conversion. The Series C Preferred Stock converted to Common Stock on a 1-for-3 basis."}],"balance_after":100969,"source":{"system":"sec-edgar","filing":"0001209191-17-035152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181190/000120919117035152/doc4.xml","form_type":"4"}},{"id":4311074,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-22T21:02:15.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":2434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full one year from grant date on May 18, 2018."}],"balance_after":2434,"derivative":{"exercise_price":38.76,"exercise_date":"2018-05-18","expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":2434},"source":{"system":"sec-edgar","filing":"0001140361-17-021759","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000114036117021759/doc1.xml","form_type":"4"}},{"id":4311073,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21255,"kind":"person","name":"MUIR GLENN P","position":1,"cik":"0001181190","reported_name":"MUIR GLENN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-22T21:02:15.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":1206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Muir was awarded 1,206 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 18, 2018. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":2969,"source":{"system":"sec-edgar","filing":"0001140361-17-021759","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000114036117021759/doc1.xml","form_type":"4"}}]}